Answer
For topical betamethasone valerate (Betnovate Cream), pregnancy data are limited and animal studies show foetal abnormalities of uncertain human relevance, so use should only be considered when maternal benefit outweighs foetal risk, using the minimum quantity for the minimum duration.
Sources for this answer
- Betnovate CreamGlaxoSmithKline UK · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 19Document updated
Sources checked